Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank93
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-1.68
↑ 51% vs avg
Percentile
P93
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
-3.45
Historical baseline
PeriodValueYoY Change
2025-1.68+43.0%
2024-2.94+45.6%
2023-5.41-79.6%
2022-3.01+17.7%
2021-3.66+39.2%
2020-6.01-13.3%
2019-5.31-104.1%
2018-2.60-6.7%
2017-2.44-62.4%
2016-1.50-